Inventor
LOPEZ OMAR D
US44 patents
⚠️ This page may combine multiple inventors who share the name “LOPEZ OMAR D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
23 patentsUS7659270B2Feb 9, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO72 citations98
US7759495B2Jul 20, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO41 citations96
US7745636B2Jun 29, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO53 citations94
US7741347B2Jun 22, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO52 citations94
US7704992B2Apr 27, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO58 citations94
US8642025B2Feb 4, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO12 citations92
US7906655B2Mar 15, 2011
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO37 citations92
US8377980B2Feb 19, 2013
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO22 citations91
US9227961B2Jan 5, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO6 citations84
US8846023B2Sep 30, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO7 citations84
US8735398B2May 27, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO6 citations83
US9326973B2May 3, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO12 citations79
US9776981B2Oct 3, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO2 citations73
US9340520B2May 17, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US9303007B2Apr 5, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations73
US9018390B2Apr 28, 2015
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US8362020B2Jan 29, 2013
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US6930100B2Aug 16, 2005
Phosphate prodrugs of fluoroxindoles
BRISTOL MYERS SQUIBB CO2 citations55
US9758487B2Sep 12, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US9717712B2Aug 1, 2017
Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
BRISTOL MYERS SQUIBB CO1 citations52
US7169803B2Jan 30, 2007
N-substituted prodrugs of fluorooxindoles
BRISTOL MYERS SQUIBB CO1 citations52
US10617675B2Apr 14, 2020
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US9770439B2Sep 26, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations37
BACHAND CAROL
6 patentsUS8574563B2Nov 5, 2013
Hepatitis C virus inhibitors
BACHAND CAROL18 citations92
US8303944B2Nov 6, 2012
Hepatitis C virus inhibitors
BACHAND CAROL36 citations92
US8147818B2Apr 3, 2012
Hepatitis C virus inhibitors
BACHAND CAROL22 citations92
US8492553B2Jul 23, 2013
Hepatitis C virus inhibitors
BACHAND CAROL11 citations84
US8288562B2Oct 16, 2012
Hepatitis C virus inhibitors
BACHAND CAROL9 citations84
US8093243B2Jan 10, 2012
Hepatitis C virus inhibitors
BACHAND CAROL5 citations62
ALCATEL LUCENT USA INC
5 patentsUS7502160B2Mar 10, 2009
Speckle reduction in laser-projector images
ALCATEL LUCENT USA INC30 citations92
US7560817B2Jul 14, 2009
Interconnect including a pliable surface and use thereof
ALCATEL LUCENT USA INC6 citations73
US7862183B2Jan 4, 2011
Speckle reduction using a tunable liquid lens
ALCATEL LUCENT USA INC6 citations60
US7659591B2Feb 9, 2010
Apparatus having a layer of material configured as a reservoir having an interior capable of holding a liquid
ALCATEL LUCENT USA INC0 citations52
US7488614B2Feb 10, 2009
Providing a charge dissipation structure for an electrostatically driven device
ALCATEL LUCENT USA INC0 citations51
LUCENT TECHNOLOGIES INC
3 patentsUS6781744B1Aug 24, 2004
Amplification of MEMS motion
LUCENT TECHNOLOGIES INC25 citations92
US6998758B2Feb 14, 2006
Deformable MEMS mirror with membrane actuated by application of torque
LUCENT TECHNOLOGIES INC6 citations62
US7452741B2Nov 18, 2008
Process for manufacturing an apparatus that protects features during the removal of sacrificial materials
LUCENT TECHNOLOGIES INC0 citations52